K Haseroth

435 total citations
9 papers, 366 citations indexed

About

K Haseroth is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, K Haseroth has authored 9 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Genetics and 3 papers in Surgery. Recurrent topics in K Haseroth's work include Estrogen and related hormone effects (4 papers), Hormonal Regulation and Hypertension (3 papers) and Analytical Methods in Pharmaceuticals (1 paper). K Haseroth is often cited by papers focused on Estrogen and related hormone effects (4 papers), Hormonal Regulation and Hypertension (3 papers) and Analytical Methods in Pharmaceuticals (1 paper). K Haseroth collaborates with scholars based in Germany and Australia. K Haseroth's co-authors include Michael Christ, Martin Wehling, Martin Feuring, Elisabeth Falkenstein, Dirk Gerdes, Andreas Guenther, Martin F. Wehling, Stefan Berger, S. Rossol and Wolfgang Stremmel and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Clinical & Experimental Immunology and International Journal of Cardiology.

In The Last Decade

K Haseroth

9 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K Haseroth Germany	7	141	113	77	73	68	9	366
Yoshikuni Yamamoto Japan	10	74 0.5×	76 0.7×	137 1.8×	51 0.7×	16 0.2×	12	382
Rocío García de la Garza Spain	8	114 0.8×	104 0.9×	31 0.4×	88 1.2×	59 0.9×	14	461
Claudia Raggi Italy	15	37 0.3×	165 1.5×	58 0.8×	54 0.7×	22 0.3×	23	455
Wanqing Liu United States	5	103 0.7×	43 0.4×	42 0.5×	32 0.4×	56 0.8×	6	300
Federico Oldoni United States	10	162 1.1×	84 0.7×	135 1.8×	93 1.3×	26 0.4×	13	356
Øystein Aagenæs Norway	13	144 1.0×	74 0.7×	19 0.2×	127 1.7×	13 0.2×	23	417
Christina‐Maria Flessa Greece	7	72 0.5×	84 0.7×	25 0.3×	36 0.5×	50 0.7×	11	319
Marta Montori-Grau Spain	12	43 0.3×	202 1.8×	39 0.5×	47 0.6×	11 0.2×	16	387
Yaron Arbel Israel	4	55 0.4×	80 0.7×	31 0.4×	23 0.3×	67 1.0×	8	273
Michael Estep United States	12	76 0.5×	152 1.3×	45 0.6×	48 0.7×	159 2.3×	21	491

Countries citing papers authored by K Haseroth

Since Specialization

Citations

This map shows the geographic impact of K Haseroth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Haseroth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Haseroth more than expected).

Fields of papers citing papers by K Haseroth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Haseroth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Haseroth. The network helps show where K Haseroth may publish in the future.

Co-authorship network of co-authors of K Haseroth

This figure shows the co-authorship network connecting the top 25 collaborators of K Haseroth. A scholar is included among the top collaborators of K Haseroth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Haseroth. K Haseroth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Haseroth, K, et al.. (2001). Acute effects of a single oral dose of carvedilol on cardiac sympathovagal balance in man. International Journal of Clinical Pharmacology and Therapeutics. 39(7). 315–321. 3 indexed citations

Haseroth, K, Michael Christ, Elisabeth Falkenstein, & Martin Wehling. (2000). Aldosterone- and Progesterone-Membrane-Binding Proteins New Concepts of Nongenomic Steroid Action. Current Protein and Peptide Science. 1(4). 385–401. 9 indexed citations

Haseroth, K, et al.. (2000). Effects of progestin–estrogen replacement therapy on QT-dispersion in postmenopausal women. International Journal of Cardiology. 75(2-3). 161–165. 39 indexed citations

Gerdes, Dirk, et al.. (2000). Nongenomic Actions of Steroids - From the Laboratory to Clinical Implications. Journal of Pediatric Endocrinology and Metabolism. 13(7). 853–78. 19 indexed citations

Haseroth, K, Dirk Gerdes, Stefan Berger, et al.. (1999). Rapid Nongenomic Effects of Aldosterone in Mineralocorticoid-Receptor-Knockout Mice. Biochemical and Biophysical Research Communications. 266(1). 257–261. 114 indexed citations

Hoffmann, Ursula, G. Huhle, K Haseroth, D. L. Heene, & Job Harenberg. (1999). A fatal complication in a patient with heparin-induced thrombocytopenia type II re-exposed to heparin. European Journal of Orthopaedic Surgery & Traumatology. 9(3). 205–207. 2 indexed citations

Feuring, Martin, et al.. (1999). Inhibition of platelet aggregation after intake of acetylsalicylic acid detected by a platelet function analyzer (PFA-100).. PubMed. 37(12). 584–8. 34 indexed citations

Kallinowski, B., K Haseroth, George Marinos, et al.. (1998). Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection. Clinical & Experimental Immunology. 111(2). 269–277. 100 indexed citations

Christ, Michael, K Haseroth, Elisabeth Falkenstein, & Martin Wehling. (1997). Nongenomic Steroid Actions: Fact or Fantasy?. Vitamins and hormones. 57. 325–373. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact